UBS AM
TRHC

UBS AM’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

UBS AM’s Portfolio TRHC Stock Details TRHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24,377
Closed -$140K – 2801
2022
Q1 		$140K Hold
24,377
– – ﹤0.01% 2712
2021
Q4 		$366K Hold
24,377
– – ﹤0.01% 2639
2021
Q3 		$639K Buy
24,377
+2,710
+13% +$99.8K ﹤0.01% 2396
2021
Q2 		$1.08M Buy
21,667
+1,663
+8% +$74.4K ﹤0.01% 2162
2021
Q1 		$921K Sell
20,004
-186,101
-90% -$8.88M ﹤0.01% 2131
2020
Q4 		$8.83M Sell
206,105
-12,867
-6% -$488K ﹤0.01% 1101
2020
Q3 		$8.93M Buy
218,972
+2,742
+1% +$137K ﹤0.01% 972
2020
Q2 		$11.8M Buy
216,230
+10,957
+5% +$627K 0.01% 863
2020
Q1 		$10.7M Sell
205,273
-32,671
-14% -$1.77M 0.01% 845
2019
Q4 		$11.6M Buy
237,944
+3,312
+1% +$155K 0.01% 903
2019
Q3 		$12.9M Buy
234,632
+73,946
+46% +$4.23M 0.01% 872
2019
Q2 		$8.02M Sell
160,686
-2,971
-2% -$148K 0.01% 1026
2019
Q1 		$9.23M Sell
163,657
-2,367
-1% -$141K 0.01% 953
2018
Q4 		$10.6M Sell
166,024
-42,918
-21% -$3.04M 0.01% 858
2018
Q3 		$17M Sell
208,942
-102,971
-33% -$7.54M 0.01% 804
2018
Q2 		$19.9M Sell
311,913
-10,040
-3% -$492K 0.02% 768
2018
Q1 		$12.5M Sell
321,953
-18,821
-6% -$660K 0.01% 872
2017
Q4 		$9.56M Buy
+340,774
New +$9.98M 0.01% 931

Other funds holding TRHC

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
RP
Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CS
Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

UBS AM's TRHC Position: Q2 2022 in Review

UBS AM sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q2 2022, closing a stake of 24,377 shares — an estimated $140K sold.

UBS AM first reported a position in TRHC in Q4 2017 and held it in 18 quarters. The position peaked at $19.9M in Q2 2018. 96 funds tracked by Wall St. Rank hold TRHC as of Q2 2022.

  • UBS AM reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • UBS AM sold 24,377 Tabula Rasa HealthCare, Inc. Common Stock shares in Q2 2022, an estimated $140K.
  • UBS AM first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2017 and held it in 18 quarters.
  • UBS AM's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $19.9M in Q2 2018.
  • 96 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q2 2022.

Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.